MUSC Cardiovascular Imaging’s Post

New review on the European Heart Journal 💻 The HeartSim research team at PrediSurge, in partnership with the University of Ottawa Heart Institute and Hôpital Saint Joseph of Marseille, has contributed a significant study to the European Heart Journal Cardiovascular Imaging, demonstrating the precision of our PlanOp® Structural Heart software in simulating Mitral Valve interventions. This work, which reflects an impact factor of 6.3, marks an important advancement in the field of cardiovascular care. Our research focused on a case study involving a 73-year-old patient, successfully treated with a Mitraclip XTL® for severe mitral regurgitation. The application of our finite element prototype software accurately predicted the outcomes of this intervention, offering a promising tool for future cardiovascular treatments. This publication underscores the potential of digital simulation technologies to improve patient outcomes and supports our ongoing commitment to innovation in healthcare: https://bit.ly/3U9ILhW 🌐 #cardiovascular #care #digital #solutions #planop #clinicians #technology #digitaltwin

Photon Counting CT: Improved Cost-effectiveness and decreased complications against Standard Energy-Integrating Detector-CT. Another important advantage.

🌍 Innovation Spotlight: BiVacor – The Future of Artificial Hearts The third invention in our Greatest Inventions of 2024 series showcases a groundbreaking development in cardiac care. Nearly 25 years after losing his father to heart failure, Australian biomedical engineer Daniel Timms is transforming the future of medicine with his company, BiVacor. BiVacor has developed an artificial heart that mimics the function of a real human heart, propelling blood throughout the body. This year, as part of an ongoing feasibility study, three U.S. patients received BiVacor hearts. These artificial hearts kept the patients alive long enough to receive donor organs—a remarkable milestone in medical innovation. Daniel Timms’ ambitions don’t stop at short-term solutions. If early trials prove successful, BiVacor plans to test the device’s ability to function indefinitely, potentially eliminating the need for live-organ transplants. This groundbreaking innovation could redefine cardiac care, offering hope to countless patients and families worldwide. “This device didn’t exist for my family,” Timms says, “but it could be life-changing—and life-saving—for others.” What do you think about the potential of artificial hearts to replace live-organ transplants? Share your thoughts in the comments below, and stay tuned as we continue to spotlight the Greatest Inventions of 2024! Richard DiPilla Jeffrey Vahanian, CFP® Ligia Chacón Hernández Vinnie Curcio Jerin Hossain #Innovation #GreatestInventions #VattIPManagement #BiVacor #ArtificialHeart #MedicalBreakthroughs #TechnologyForGood #Biotechnology #BiomedicalEngineering

We’re pleased to share a video featuring Dr. Tilman Schubert, Senior Interventional Neuroradiologist at the Universitätsspital Zürich. In the video, Dr. Schubert shares his perspective on our telerobotic intervention system and its potential applications in stroke care. Thank you to Dr. Schubert and our clinical collaborators for their valuable feedback and support. This video was showcased at the Wyss Zurich Annual Event last month, and we’re excited to now share it with you. #StrokeCare #MedicalInnovation #Telerobotics #NanoflexRobotics 

Tivic Health Systems, Inc. (Nasdaq: TIVC), a pioneer in bioelectronic medicine, consistently demonstrates its commitment to advancing medical technology through rigorous research and innovative practices.    In a collaborative effort with The Feinstein Institutes for Medical Research at Northwell Health, Tivic Health has substantiated the effectiveness of its proprietary non-invasive cervical vagus nerve stimulation (ncVNS) method. This technology, designed to elicit responses across the autonomic, cardiac, and central nervous systems, holds promising implications for the treatment of multiple significant diseases.   Further details from the pilot study reveal Tivic Health's ncVNS approach resulted in a remarkable 97% increase in heart rate variability, alongside notable enhancements in brain activity metrics, such as a 24% rise in frontal theta power and a 66% reduction in frontal gamma power. Such findings not only underscore the potential of ncVNS in treatment of medical conditions but also reaffirm Tivic Health's role at the forefront of non-invasive medical solutions.    This commitment is echoed by Tivic Health’s leadership, with Chief Scientific Officer, Dr. Blake Gurfein, PhD, noting the considerable impact of these results on future product development and market strategies. This dedication to innovation is a core component of Tivic Health's mission to improve life's vibrancy through cutting-edge bioelectronic medicine.   https://lnkd.in/g46CNiBW   #tivic #nasdaq #tivc #clearup #bioelectronic #sinus  Jennifer Ernst

🔬 Breaking: Boston Scientific Secures FDA Approval for Revolutionary Cardiac Ablation Technology TL;DR: ✅ Advanced pulsed field ablation catheter with navigation capabilities ✅ FDA approval secured October 21, 2024 ✅ Game-changer for cardiac arrhythmia treatment This milestone positions Boston Scientific as a leader in electrophysiology innovation, signaling a major shift toward minimally invasive cardiac care solutions. Strategic Takeaways for Biotech Leaders: • Consider integrating navigation and precision tech into your product pipeline • Explore strategic partnerships in advanced catheter development • Strengthen relationships with cardiac care stakeholders • Monitor regulatory pathways for similar innovations What's your take on this advancement in cardiac care technology? Are you seeing similar innovations in your sector? Let's discuss below. 👇 #BiotechInnovation #MedicalDevice #CardiacCare #FDAApproval #HealthcareTech

Biomedical Optics Express [#OPG_BOEx] research investigates the use of intravascular polarization-sensitive optical coherence tomography to assess thrombus morphology and composition: https://ow.ly/mN4N50SaN3T Deep venous thrombosis (DVT) is a medical condition with significant post-event morbidity and mortality coupled with limited treatment options; with treatment highly dependent on the composition of the thrombus. Massachusetts General Hospital, Harvard Medical School and Mayo Clinic researchers found that PS-OCT imaging could be integrated with advanced catheter-based treatment strategies and serve to guide therapeutic decision-making and deployment. Written by: Georgia L. Jones, Hassan Albadawi, Lida P. Hariri, Brett E. Bouma, Rahmi Oklu, and Martin Villiger #medicine #biomedical #healthcare #medicaltechnology

ICYMI: AuntMinnie.com spotlighted the FDA's clearance for our MRI chest coil for use with GE HealthCare scanners! We are thrilled to continue spreading news about this clearance because it means even more medical institutions will have access to our revolutionary Xenon MRI technology for both research and clinical use. Together with leading medical institutions using our technology, we are transforming pulmonary medicine through direct visualization of lung function. Read the article: https://lnkd.in/eGHMsdxZ #PulmonaryMedicine #LungMRI #Innovation #PulmonaryImaging #XenonMRI

To kick of Medical Ultrasound Awareness Month, we are bringing you a series of conversations between BMUS' outgoing President, Prof Adrian Lim, and our President Elect, Dr Peter Cantin. Today's question for these titans in the field was: Why did you both join BMUS initially, and to follow up; Why did you decide to get involved in the management and delivery of BMUS?

Ready to take your cardiovascular imaging research to the next level? 🫀📊 This #EACVI guide offers a practical roadmap for designing and conducting imaging protocols in clinical trials—perfect for researchers, fellows, and Ph.D. students. 🔗 https://loom.ly/KA9_Gb4 #CardiacImaging #cvimaging #CardioResearch